Related Experiment Video

Updated: Jan 13, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
08:56

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes

Published on: October 10, 2025

614

Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding

Anna Duarri1, Oscar Teijido, Tania López-Hernández

  • 1CGMM-IDIBELL, l'Hospitalet de Llobregat, Barcelona, Spain.

Human Molecular Genetics
|September 2, 2008
PubMed

Insights

Mutations in the MLC1 gene cause Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC) by reducing protein levels. Improving MLC1 expression may offer a treatment strategy for this rare leukodystrophy.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare leukodystrophy.
  • It is primarily caused by mutations in the MLC1 gene, which encodes a plasma membrane protein.
  • The function of MLC1 protein is largely unknown, but it is expressed in glial cells and neurons.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying MLC caused by MLC1 mutations.
  • To determine the impact of disease-causing mutations on MLC1 protein expression and localization.
  • To explore potential therapeutic strategies for MLC.

Main Methods:

  • Utilized Xenopus oocytes and mammalian cell lines to study MLC1 expression.
  • Employed primary cultures of rat astrocytes and human monocytes to validate findings in endogenous systems.
  • Applied biochemical, pharmacological, and imaging techniques to analyze protein degradation pathways and cell surface expression.
  • Tested the effect of low temperature and chemical chaperones on mutant MLC1 expression.

Main Results:

  • Disease-associated MLC1 missense mutations significantly reduced total and plasma membrane expression levels.
  • Impaired expression was confirmed in relevant cell types, including astrocytes and monocytes.
  • Increased endoplasmic reticulum-associated degradation and endo-lysosomal degradation contributed to reduced cell surface expression.
  • Low temperature and glycerol (a chemical chaperone) rescued the expression defect of mutant MLC1.

Conclusions:

  • MLC1 mutations lead to reduced protein levels in vivo, likely due to impaired expression and increased degradation.
  • MLC can be classified as a conformational disease, as its defects can be rescued by conditions that stabilize protein folding.
  • Pharmacological strategies aimed at enhancing MLC1 expression hold promise for treating MLC patients.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations08:22

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

9.0K
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model05:12

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model

Published on: September 4, 2017

11.3K

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.6K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
698
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.7K